Kenneth T. Mills, President and CEO at REGENXBIO Inc. (RGNX), sold 20,000 shares at $39.91 ($795K) on 2019-09-19, disclosed to the SEC on 2019-09-23.
Open-market sale of $795k RGNX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.19 | 2,227 | $87K | 11.0% |
| 2 | $39.19 | 2,227 | $87K | 11.0% |
| 3 | $39.91 | 7,773 | $310K | 39.0% |
| 4 | $39.91 | 7,773 | $310K | 39.0% |
| Total | $39.75 avg | 20,000 | $795K | 100% |
| Filing → |
| RGNX | SELL | 2024-07-18 | $33K | — | Filing → |
| RGNX | SELL | 2024-05-16 | $237K | — | Filing → |
| RGNX | SELL | 2024-04-17 | $273K | — | Filing → |